Hematopoietic Stem Cell Transplantation for Children With Inborn Errors of Metabolism: Single Center Experience Over

Venkateswaran Vellaichamy Swaminathan1, Satishkumar Meena2, Harika Varla2

  • 1Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai 600 035, Tamil Nadu. Correspondence to: Dr Venkateswaran Vellaichamy Swaminathan, Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, 320, Padma Complex, Anna Salai, Teynampet, Chennai 600 035, Tamil Nadu. vsv.mezos97@gmail.com.

Indian Pediatrics
|June 28, 2022
PubMed

Insights

Hematopoietic stem cell transplantation (HSCT) offers a curative option for children with inborn errors of metabolism (IEM). Early HSCT is crucial for preventing end-organ damage and improving survival rates in pediatric patients.

Area of Science:

  • Pediatric Hematology
  • Metabolic Disorders
  • Transplantation Medicine

Background:

  • Inborn errors of metabolism (IEM) are a group of genetic disorders affecting metabolic pathways.
  • Hematopoietic stem cell transplantation (HSCT) is a potential curative treatment for certain IEMs.
  • Data on HSCT outcomes in pediatric IEM patients are essential for treatment planning.

Purpose of the Study:

  • To present outcome data for hematopoietic stem cell transplantation (HSCT) in children diagnosed with inborn errors of metabolism (IEM).
  • To evaluate the efficacy and survival rates of HSCT in this pediatric population.

Main Methods:

  • Retrospective analysis of pediatric patients (up to 18 years) with IEM who underwent HSCT.
  • Data collected between January 2002 and December 2020.
  • Inclusion of various IEMs including mucopolysaccharidosis, Gaucher disease, X-linked adrenoleukodystrophy, metachromatic leukodystrophy, and Krabbe disease.

Main Results:

  • 24 children with IEM underwent HSCT.
  • Engraftment was achieved in 91% of patients.
  • Overall survival was 72%, with progression-free survival at 68%.
  • Specific survival rates varied by IEM type, with 100% progression-free survival for metachromatic leukodystrophy and Krabbe disease.

Conclusions:

  • Hematopoietic stem cell transplantation (HSCT) is a viable curative treatment for children with inborn errors of metabolism (IEM).
  • Performing HSCT at an early age is critical to prevent irreversible end-organ damage.
  • The study highlights the importance of timely HSCT for improving long-term outcomes in pediatric IEM patients.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
489
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
237
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.3K